|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/337 | (2006.01) |
| A61K 38/15 | (2006.01) | ||
| A61K 31/472 | (2006.01) | ||
| A61K 31/495 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3532059 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17864117.1 |
| Date of filing the European patent application | 2017-10-26 | |
| (97) | Date of publication of the European application | 2019-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-26 |
| (46) | Date of publication of the claims translation | 2022-05-25 |
| (86) | Number | PCT/US2017/058614 |
| Date | 2017-10-26 |
| (87) | Number | WO 2018/081475 |
| Date | 2018-05-03 |
| (30) | Number | Date | Country code |
| 201662413763 P | 2016-10-27 | US | |
| 201762560840 P | 2017-09-20 | US |
| (72) |
CHO, Robert , US
STAFFORD, Jeffrey Alan , US
|
| (73) |
Celgene Quanticel Research, Inc. ,
9393 Towne Centre Drive, San Diego, CA 92129,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Bromodomeno ir papildomo galinio baltymo inhibitorių derinio terapija |
| BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY |
| Payment date | Validity (years) | Amount | |
| 2023-10-09 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-10-26 |